Add BrightSurf on Google Email

SpectruMedix Corporation


Novel AIDS-Directed Technology: Approach Permits Optimization Of Existing Drug Therapies And Targeted, Patient-Specific Treatment

Researchers have developed a new diagnostic technique to measure T cell proliferation rates in AIDS patients, revealing that the body's capacity to form new cells is key to T cell counts. The technique allows for personalized treatment optimization and real-time disease monitoring.

SourceSpectruMedix Corporation·JournalProceedings of the National Academy of Sciences·DateFeb 3, 1998